HARPOON THERAPEUTICS INC (HARP)
US41358P2056 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 17.70M | 51.60M | 44.70M | 21.20M | 88.70M | |||
| Marketable Securities | 13.90M | 1.50M | 90.40M | 104.90M | 59.30M | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 2.70M | 1.60M | 2.60M | 3.70M | 2.50M | |||
| Total Current Assets | 34.30M | 54.70M | 137.70M | 129.80M | 150.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.40M | 18.10M | 15.40M | 16.80M | 18.40M | |||
| Investments And Advances | N/A | 0.00 | 1.50M | 23.90M | 7.10M | |||
| Other Non-Current Assets | 900.00K | 900.00K | 900.00K | 1.10M | 500.00K | |||
| Total Non-Current Assets | 13.30M | 19.00M | 17.80M | 41.80M | 26.00M | |||
| TOTAL ASSETS | 47.60M | 73.70M | 155.50M | 171.60M | 176.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 14.70M | 16.80M | 19.00M | 15.00M | 8.70M | |||
| Accounts Payable | 3.40M | 4.70M | 2.70M | 1.60M | 2.60M | |||
| Other Current Liabilities | 0.00 | 30.90M | 37.50M | 31.30M | 11.20M | |||
| Total Current Liabilities | 18.10M | 52.40M | 59.10M | 47.90M | 22.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 8.80M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 16.10M | 15.90M | 38.20M | 69.80M | 59.90M | |||
| Total Non-Current Liabilities | 24.90M | 15.90M | 38.30M | 69.90M | 59.90M | |||
| TOTAL LIABILITIES | 43.00M | 68.30M | 97.40M | 117.80M | 82.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -364.60M | -352.50M | -284.80M | -168.10M | -118.20M | |||
| Additional Paid In Capital | 369.10M | 357.90M | 342.90M | 221.90M | 212.30M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 4.10M | 3.60M | 3.30M | 2.60M | 2.50M | |||
| Tangible Book Value per Share | 1.10 | 1.50 | 17.61 | 20.69 | 37.68 | |||
| Total Shareholders' Equity | 4.50M | 5.40M | 58.10M | 53.80M | 94.20M | |||
| TOTAL LIABILITIES AND EQUITY | 47.60M | 73.70M | 155.50M | 171.60M | 176.60M | |||
| Statistics | ||||||||
| Debt/Equity | 1.96 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.90 | 1.04 | 2.33 | 2.71 | 6.69 | |||
| Return On Assets (ROA) | -64.08% | -91.90% | -75.06% | -29.09% | -31.47% | |||
| Return On Equity (ROE) | -677.78% | -1254.26% | -200.90% | -92.77% | -58.99% | |||
All data in USD